Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Hartung

Showing results (131-140 of 601) with videos related to

Pageof 61
Sort By:
Glia|July 6, 2013
Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesionsSabine Pfeifenbring, Imke Metz, David Kremer, et al.
Nature Reviews. Neurology|March 5, 2016
Disease-modifying therapies and infectious risks in multiple sclerosisAlexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Plos One|December 19, 2017
Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsManda V Sasidhar, Sai Krishnaveni Chevooru, Oliver Eickelberg, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 2006
High throughput analysis of TCR-beta rearrangement and gene expression in single T cellsDun Zhou, Rajneesh Srivastava, Verena Grummel, et al.
Journal of Neuroinflammation|March 15, 2018
Teriflunomide promotes oligodendroglial differentiation and myelinationPeter Göttle, Anastasia Manousi, David Kremer, et al.
Brain Communications|November 19, 2020
Neurological manifestations of severe acute respiratory syndrome coronavirus 2-a controversy 'gone viral'Moritz Förster, Vivien Weyers, Patrick Küry, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 11, 2020
Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) studyVera Bril, Hans-Peter Hartung, John-Philip Lawo, et al.
Current Opinion in Neurology|June 8, 2022
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinationsMaura Pugliatti, Thomas Berger, Hans-Peter Hartung, et al.
Blood|February 1, 2008
The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humansFabian Zohren, Diamandis Toutzaris, Viola Klärner, et al.
The American Journal of Pathology|September 26, 2003
CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destructionMichael Schroeter, Guido Stoll, Robert Weissert, et al.
Pageof 61

Showing results (131-140 of 601) with videos related to

Sort By:
Pageof 61
Glia|July 6, 2013
Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesionsSabine Pfeifenbring, Imke Metz, David Kremer, et al.
Nature Reviews. Neurology|March 5, 2016
Disease-modifying therapies and infectious risks in multiple sclerosisAlexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Plos One|December 19, 2017
Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsManda V Sasidhar, Sai Krishnaveni Chevooru, Oliver Eickelberg, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 2006
High throughput analysis of TCR-beta rearrangement and gene expression in single T cellsDun Zhou, Rajneesh Srivastava, Verena Grummel, et al.
Journal of Neuroinflammation|March 15, 2018
Teriflunomide promotes oligodendroglial differentiation and myelinationPeter Göttle, Anastasia Manousi, David Kremer, et al.
Brain Communications|November 19, 2020
Neurological manifestations of severe acute respiratory syndrome coronavirus 2-a controversy 'gone viral'Moritz Förster, Vivien Weyers, Patrick Küry, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 11, 2020
Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) studyVera Bril, Hans-Peter Hartung, John-Philip Lawo, et al.
Current Opinion in Neurology|June 8, 2022
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinationsMaura Pugliatti, Thomas Berger, Hans-Peter Hartung, et al.
Blood|February 1, 2008
The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humansFabian Zohren, Diamandis Toutzaris, Viola Klärner, et al.
The American Journal of Pathology|September 26, 2003
CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destructionMichael Schroeter, Guido Stoll, Robert Weissert, et al.
Pageof 61